Chinese Peptide Company, Medtide Subsidiary, Receives National 'Little Giant' Designation

Time：2024-09-14

As part of China's ongoing initiative to cultivate "specialized, refined, distinctive, and innovative" small and medium-sized enterprises, the Ministry of Industry and Information Technology (MIIT) has recently completed its selection of the 6th batch of "Little Giant" enterprises and conducted reviews of the 3rd batch. Chinese Peptide Company has been awarded the prestigious "Little Giant" enterprise designation in Zhejiang Province as part of this latest round of recognition.

About National"Specialized, Fine, Unique and New" Little Giant Enterprises

National "Specialized, Fine, Unique and New" Little Giant Enterprisesrefer to leading enterprises in core fields of industrial foundations and keylinks of industrial chains. They are dedicated to niche markets, feature strongtechnological innovation capabilities, high market share, mastery of key coretechnologies, and excellent quality and efficiency. This is an"authoritative certification" established by the state to encouragesmall and medium-sized enterprises to achieve "specialized operation,refined output, characteristic processes, and innovative products".

About Chinese Peptide Company

Chinese Peptide Company is a peptide andoligonucleotide-focused Contract Research, Development, and ManufacturingOrganization (CRDMO), offering full-cycle services ranging from early-stagediscovery, pre-clinical research and clinical development to commercial-stageproduction.

Return

Previous Article：Medtide Subsidiary Chinese Peptide Company Receives ISO 22716:2007 International Certification Next Article：Chinese Peptide Company, Medtide Subsidiary, Clears FDA On-Site Inspection